{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:33:22Z","timestamp":1792690402628,"version":"4.5.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":320,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Intensive Care"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1186\/s13613-025-01460-0","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T22:53:52Z","timestamp":1745621632000},"page":"56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Nirsevimab prophylaxis on pediatric intensive care hospitalization for severe acute bronchiolitis: a clinical and economic analysis"],"prefix":"10.1016","volume":"15","author":[{"given":"Sarah","family":"Touati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Debs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Morin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Jule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Claude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5423-5532","authenticated-orcid":false,"given":"Pierre","family":"Tissieres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Beggaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Blanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Boithias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Brognion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Carriere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramy","family":"Charbel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mafoudia","family":"Conde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir L","family":"Cousin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narjess","family":"Ghali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9mence","family":"Marais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Miatello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Oddone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Tissi\u00e8res","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9725","key":"10.1186\/s13613-025-01460-0_bb0010","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(10)60206-1","article-title":"Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis","volume":"375","author":"Nair","year":"2010","journal-title":"Lancet"},{"issue":"26","key":"10.1186\/s13613-025-01460-0_bb0015","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1056\/NEJMoa2309189","article-title":"Nirsevimab for prevention of hospitalizations due to RSV in infants","volume":"389","author":"Drysdale","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1186\/s13613-025-01460-0_bb0020","doi-asserted-by":"crossref","unstructured":"Ares-G\u00f3mez S, Mallah N, Santiago-P\u00e9rez MI, et al. Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study. Lancet Infect Dis. 2024;24(8):817\u2013828. https:\/\/doi.org\/10.1016\/S1473-3099(24)00215-9. Epub 2024 Apr 30. Erratum in: Lancet Infect Dis. 2024;24(7):e419. https:\/\/doi.org\/10.1016\/S1473-3099(24)00355-4.","DOI":"10.1016\/S1473-3099(24)00355-4"},{"issue":"2","key":"10.1186\/s13613-025-01460-0_bb0025","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1056\/NEJMoa2314885","article-title":"Nirsevimab and hospitalization for RSV bronchiolitis","volume":"391","author":"Assad","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1186\/s13613-025-01460-0_bb0030","unstructured":"R Core Team (2021). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. 2021. https:\/\/www.R-project.org\/"},{"issue":"10","key":"10.1186\/s13613-025-01460-0_bb0035","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.40997","article-title":"Respiratory syncytial virus and US pediatric intensive care utilization","volume":"7","author":"Shanklin","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1186\/s13613-025-01460-0_bb0040","doi-asserted-by":"crossref","first-page":"1441786","DOI":"10.3389\/fpubh.2024.1441786","article-title":"The effectiveness of nirsevimab in reducing the burden of disease due to respiratory syncytial virus (RSV) infection over time in the Madrid region (Spain): a prospective population-based cohort study","volume":"12","author":"Barbas Del Buey","year":"2024","journal-title":"Front Public Health"},{"issue":"9","key":"10.1186\/s13613-025-01460-0_bb0045","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/archdischild-2024-327153","article-title":"Effectiveness of nirsevimab immunoprophylaxis against respiratory syncytial virus-related outcomes in hospital and primary care settings: a retrospective cohort study in infants in Catalonia (Spain)","volume":"109","author":"Coma","year":"2024","journal-title":"Arch Dis Child"},{"issue":"6","key":"10.1186\/s13613-025-01460-0_bb0050","doi-asserted-by":"crossref","DOI":"10.1111\/irv.13311","article-title":"Nirsevimab effectiveness against cases of respiratory syncytial virus bronchiolitis hospitalised in paediatric intensive care units in France, September 2023-January 2024","volume":"18","author":"Paireau","year":"2024","journal-title":"Influenza Other Respir Viruses"},{"issue":"9","key":"10.1186\/s13613-025-01460-0_bb0055","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1007\/s00431-024-05634-z","article-title":"Impact of universal immunization program with monoclonal antibody nirsevimab on reducing the burden of serious bronchiolitis that need pediatric intensive care","volume":"183","author":"Alejandre","year":"2024","journal-title":"Eur J Pediatr"},{"issue":"1","key":"10.1186\/s13613-025-01460-0_bb0060","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s00134-013-3129-z","article-title":"Improved clinical and economic outcomes in severe bronchiolitis with pre-emptive nCPAP ventilatory strategy","volume":"40","author":"Essouri","year":"2014","journal-title":"Intensive Care Med"},{"key":"10.1186\/s13613-025-01460-0_bb0065","article-title":"Cost-effectiveness of nirsevimab for respiratory syncytial virus in infants and young children","author":"Hutton","year":"2024","journal-title":"Pediatrics"},{"issue":"5","key":"10.1186\/s13613-025-01460-0_bb0070","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-4064","article-title":"Cost-effectiveness of palivizumab for respiratory syncytial virus: a systematic review","volume":"143","author":"Mac","year":"2019","journal-title":"Pediatrics"},{"key":"10.1186\/s13613-025-01460-0_bb0075","article-title":"Cost-effectiveness analysis of nirsevimab and maternal RSVpreF vaccine strategies for prevention of Respiratory Syncytial Virus disease among infants in Canada: a simulation study","volume":"28","author":"Shoukat","year":"2023","journal-title":"Lancet Reg Health Am"},{"issue":"1","key":"10.1186\/s13613-025-01460-0_bb0080","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/apa.12428","article-title":"Infants with severe respiratory syncytial virus needed less ventilator time with nasal continuous airways pressure then invasive mechanical ventilation","volume":"103","author":"Borckink","year":"2014","journal-title":"Acta Paediatr"},{"issue":"5","key":"10.1186\/s13613-025-01460-0_bb0085","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1055\/a-0611-6109","article-title":"Differences of medical care for acute severe viral bronchiolitis in two urban areas in Europe","volume":"230","author":"Dohna-Schwake","year":"2018","journal-title":"Klin Padiatr."}],"container-title":["Annals of Intensive Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13613-025-01460-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13613-025-01460-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2110582025000500?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2110582025000500?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13613-025-01460-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T08:01:05Z","timestamp":1776672065000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2110582025000500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"alternative-id":["S2110582025000500"],"URL":"https:\/\/doi.org\/10.1186\/s13613-025-01460-0","relation":{},"ISSN":["2110-5820"],"issn-type":[{"value":"2110-5820","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nirsevimab prophylaxis on pediatric intensive care hospitalization for severe acute bronchiolitis: a clinical and economic analysis","name":"articletitle","label":"Article Title"},{"value":"Annals of Intensive Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1186\/s13613-025-01460-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2025 The Author(s) 2025. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}],"article-number":"56"}}